Ampersand Capital backs GenDx
Ampersand Capital Partners has made a minority investment in GenDx, a Dutch provider of molecular diagnostic kits and analysis software for transplantation and companion diagnostics. No financial terms were disclosed.
Ampersand Capital Partners has made a minority investment in GenDx, a Dutch provider of molecular diagnostic kits and analysis software for transplantation and companion diagnostics. No financial terms were disclosed.